Lachman Consultants is
now offering informative
and comprehensive

Calendar & Registration

Lachman has been providing
both onsite and remote
support to our clients
for many years.

Review Support Offerings

COVID-19 Survey Report:
A deeper look at the overall organizational and industry impact of the pandemic.

Read the Survey Report

Lachman Consultants Offers Support to Help U.S. Distilleries and Breweries Manufacture Hand Sanitizer.

Read the Full Story
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA and industry experts has offered compliance, regulatory affairs, and technical services to clients around the world.

Learn More About Us

Lachman Practice Groups

Three Practices
Executing One Vision

Lachman Consultants maintains three practice groups: Compliance, Regulatory Affairs, and Science and Technology. Each practice offers industry-leading experience and expertise in its area of focus.

Lachman OnCall Logo

Get the answers and guidance to your most pressing questions faster than ever before.

Now you can speak to one of our Subject Matter Experts and get the answers you need quickly on the many pressing issues arising in the life science areas that Lachman Consultants serves on a day to day basis. Whether it’s something you need to know about compliance, or a complex scientific or technical issue, Lachman OnCall™️ can provide you the timely information you require as needs arise and unforeseen questions occur.

Learn More About Lachman OnCall

OnCall Image

Recent Posts

The Lachman Consultants Blog

The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

Additional Guidance on Hand Sanitizer – Preparation, Manufacture and Temporary Compounding: The Bar is Raised

FDA issued three updated guidance documents that have revised recommen...
Read More

Consolidation of Publication for EUAs for Medical Devices Announced in the Federal Register

The Federal Register (FR), in a pre-publication notice today (here), o...
Read More

Data Integrity: Beyond Electronic Records

Contract Pharma recently published an article written by Timothy Rhine...
Read More

Orange Book Q&A Document Provides Insight to the Mysteries Inside

How many times have you had a question about the listings in the Orang...
Read More

Meeting and Application Goal Dates – Questions and Answers of Impact of COVID-19 Work

The FDA released a guidance to remain in effect until the COVID-19 pub...
Read More

New Recommended PDE Limits for Three Solvents Proposed by ICH

Today, in the Federal Register pre-publication notice (here), “the F...
Read More
Contact Us Today